Serum cystatin C and CRP are early predictive biomarkers for emergence of hypoxia in COVID-19.

ABSTRACT:

Background

In Japan, during the coronavirus disease 2019 (COVID-19) pandemic, patients with non-hypoxia are recommended to recuperate at home or in pre-hospital facilities. However, it was observed that unexpected hypoxia may occur and become severe subsequently in patients whose symptoms were initially expected to improve naturally. The aim of this study is to validate biomarkers that can predict at an early stage the emergence of hypoxia in COVID-19 patients without hypoxia.

Methods

We retrospectively enrolled 193 patients with COVID-19, excluding patients with hypoxia and severe disease from the onset. Participants were classified into two groups according to the emergence of hypoxia during the clinical course, and the laboratory data were compared to identify biomarkers

SUBMITTER: Miyata Y 

PROVIDER: S-EPMC9259004 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature